Related Experiment Video
Updated: Dec 11, 2025

Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research
Published on: March 22, 2024
Advances in Topical Hemostatic Agent Therapies: A Comprehensive Update
Liang Huang1, Geoffrey L Liu2, Alan D Kaye3,4
1Department of Anesthesiology, Perioperative and Pain Medicine, New York University Langone School of Medicine, New York, USA.
Topical hemostatic agents control severe bleeding by promoting clotting and improving tissue oxygen delivery. This review details current and emerging hemostatic materials for clinical use.
Area of Science:
- Biomedical Engineering
- Materials Science
- Emergency Medicine
Background:
- Severe hemorrhage leads to metabolic and cellular dysfunction due to poor tissue perfusion and oxygen delivery.
- Uncontrolled bleeding can result in hemodynamic instability, hypoxemia, multiple organ failure, and death.
Purpose of the Study:
- To review currently available and developing topical hemostatic materials.
- To discuss the clinical applications of these agents in achieving hemostasis.
Main Methods:
- Review of existing literature on hemostatic agents.
- Categorization of agents into topical active agents, mechanical agents, synthetic/hemisynthetic agents, and external hemostatic dressings.
Main Results:
- Various hemostatic techniques exist, including surgical methods, chemical agents, nanoparticles, and physical pressure.
- Topically-applied hemostatic agents offer significant clinical applications.
- Emerging hemostatic materials are becoming more targeted due to a better understanding of the clotting cascade.
Conclusions:
- Topical hemostatic agents are crucial for managing severe bleeding.
- A range of materials, from traditional to advanced, are available and under development.
- Continued research aims to enhance the efficacy and targeting of hemostatic agents for improved patient outcomes.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Venous Thrombosis IV: Nursing Management

